Cargando…
Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection
BACKGROUND: Interest in phage therapy has grown over the past decade due to the rapid emergence of antibiotic resistance in bacterial pathogens. However, the use of bacteriophages for therapeutic purposes has raised concerns over the potential for immune response, rapid toxin release by the lytic ac...
Autores principales: | Paul, Vivek Daniel, Sundarrajan, Sudarson, Rajagopalan, Sanjeev Saravanan, Hariharan, Sukumar, Kempashanaiah, Nanjundappa, Padmanabhan, Sriram, Sriram, Bharathi, Ramachandran, Janakiraman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224134/ https://www.ncbi.nlm.nih.gov/pubmed/21880144 http://dx.doi.org/10.1186/1471-2180-11-195 |
Ejemplares similares
-
A novel bacteriophage Tail-Associated Muralytic Enzyme (TAME) from Phage K and its development into a potent antistaphylococcal protein
por: Paul, Vivek Daniel, et al.
Publicado: (2011) -
Cloning and high-level expression of Thermus thermophilus RecA in E. coli: purification and novel use in HBV diagnostics
por: Sundarrajan, Sudarson, et al.
Publicado: (2018) -
Use of coagulation factor XIII (F13) gene as an internal control for normalization of genomic DNA’s for HLA typing
por: Neduvat, Anupama Cheleri, et al.
Publicado: (2018) -
Novel properties of recombinant Sso7d-Taq DNA polymerase purified using aqueous two-phase extraction: Utilities of the enzyme in viral diagnosis
por: Sundarrajan, Sudarson, et al.
Publicado: (2018) -
Endolysin Regulation in Phage Mu Lysis
por: Chamblee, Jake S., et al.
Publicado: (2022)